On 17 April 2018, German specialty chemicals firm Evonik opened a research hub in Singapore as part of its efforts to expand the company’s research and development footprint. Located at Biopolis, the centre will undertake research in functional surfaces and additive manufacturing, and will be a base for tissue engineering project. The lab will house 50 people.
Evonik Deputy Chairman Mr Harald Schwagger said innovation is an integral part of the group’s growth strategy. “We are actively pursuing new opportunities to boost our international R&D activities and the opening of this research hub is a significant contribution to these efforts.”